Cargando…
Classical and Novel Prognostic Markers for Breast Cancer and their Clinical Significance
The use of biomarkers ensures breast cancer patients receive optimal treatment. Established biomarkers such as estrogen receptor (ER) and progesterone receptor (PR) have been playing significant roles in the selection and management of patients for endocrine therapy. HER2 is a strong predictor of re...
Autores principales: | Taneja, Pankaj, Maglic, Dejan, Kai, Fumitake, Zhu, Sinan, Kendig, Robert D., Fry, Elizabeth A., Inoue, Kazushi |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2883240/ https://www.ncbi.nlm.nih.gov/pubmed/20567632 |
Ejemplares similares
-
Transgenic and Knockout Mice Models to Reveal the Functions of Tumor Suppressor Genes
por: Taneja, Pankaj, et al.
Publicado: (2011) -
Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
por: Fry, Elizabeth A., et al.
Publicado: (2013) -
Novel Molecular Markers for Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2016) -
Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications in Human Cancer
por: Inoue, Kazushi, et al.
Publicado: (2013) -
Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53
por: Fry, Elizabeth A., et al.
Publicado: (2020)